| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/26/2011 | WO2011036676A8 Stable cocrystals of temozolomide |
| 05/26/2011 | WO2011036521A3 Formulations comprising triptan compounds |
| 05/26/2011 | WO2011033115A3 Compounds useful against kinetoplastideae parasites |
| 05/26/2011 | WO2011026153A3 Inotilone derivatives as coherent biological response modifier (cbmr) |
| 05/26/2011 | WO2011022532A9 Methods for concomitant administration of colchicine and a second active agent |
| 05/26/2011 | WO2011020001A9 Use of ppar delta ligands for the treatment or prevention of inflammation or energy metabolism/production related diseases |
| 05/26/2011 | WO2011014872A3 Compositions and methods for diagnosing, treating or preventing neoplasias |
| 05/26/2011 | WO2011011692A3 Methods of treating and preventing/reducing the likelihood of mesial temporal lobe epilepsy (tle) |
| 05/26/2011 | WO2011011330A3 Inhibitors of d-amino acid oxidase |
| 05/26/2011 | WO2011011186A3 Hdac inhibitors and therapeutic methods using the same |
| 05/26/2011 | WO2011006097A3 Methods For Treating Toxicity |
| 05/26/2011 | WO2011005714A3 Bendamustine liposomal compositions |
| 05/26/2011 | WO2011005609A3 Imaging gastrointestinal volumes and motility |
| 05/26/2011 | WO2011005052A3 Novel arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same |
| 05/26/2011 | WO2011003103A3 Pharmacology of visual cycle modulators |
| 05/26/2011 | WO2011003064A9 Methods of treating neuropathic pain |
| 05/26/2011 | WO2011002814A3 Sulfonamido - biphenyloxyacetic acid compounds |
| 05/26/2011 | WO2011002520A3 Small molecule inhibitors of parp activity |
| 05/26/2011 | WO2011002258A3 Arginine-based amphiphilic peptide micelle |
| 05/26/2011 | WO2011000581A3 Raloxifene composition |
| 05/26/2011 | WO2011000566A3 Compounds and pharmaceutical compositions for the treatment of negative-sense ssrna virus infections |
| 05/26/2011 | WO2010148314A3 Preparation of esomeprazole and its pharmaceutically acceptable salts |
| 05/26/2011 | WO2010143188A3 Halogenated aliphatic carboxylic acids, oligomers and/or polymers thereof and their use in devitalizing external and internal neoplasms |
| 05/26/2011 | WO2010136872A3 Use of a glycosaminoglycan fixed combination and chewable composition comprising said fixed combination |
| 05/26/2011 | WO2010135329A3 Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor |
| 05/26/2011 | WO2010131922A4 Amide compound, preparation method thereof and pharmaceutical composition comprising same |
| 05/26/2011 | WO2010119387A3 A medicinal cream made using miconazole nitrate, fluticasone propionate, and chitosan, and a process to make the same |
| 05/26/2011 | WO2010119386A3 A medicinal cream made using clotrimazole, fluticasone propionate, and chitosan, and a process to make the same |
| 05/26/2011 | WO2010119368A3 A medicinal cream made using miconazole nitrate and chitosan, and a process to make the same |
| 05/26/2011 | WO2010119366A3 A medicinal cream made using fluticasone propionate, and chitosan, and a process to make the same |
| 05/26/2011 | WO2010109425A3 A medicinal steroids cream and a process to make it |
| 05/26/2011 | WO2010089566A4 Composition for treatment of skin |
| 05/26/2011 | WO2010080936A3 Chlorhexidine-containing antimicrobial laminates |
| 05/26/2011 | WO2010053600A3 Nyasol and analogs thereof for the treatment of estrogen receptor beta-mediated diseases |
| 05/26/2011 | WO2010051926A3 Halogen-substituted compounds used as pesticides |
| 05/26/2011 | WO2010032006A8 Treatment of adrenal insufficiency |
| 05/26/2011 | WO2009118758A3 Novel crystalline forms of desvenlafaxine succinate |
| 05/26/2011 | WO2007041497A3 Modulation of androgen receptor |
| 05/26/2011 | WO2006119449A3 Modified adenovirus containing a stabilized antibody |
| 05/26/2011 | US20110126303 Modified Blood Clotting Factors And Methods Of Use |
| 05/26/2011 | US20110126302 Diagnostic and therapeutic methods for efmr (epilepsy and mental retardation limited to females) |
| 05/26/2011 | US20110126300 High Through-Put Method of Screening Compounds for Pharmacological Activity |
| 05/26/2011 | US20110124887 Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidant activity |
| 05/26/2011 | US20110124872 Derivatives of pryidone and use thereof |
| 05/26/2011 | US20110124742 Composition and method of adipose cell differentiation inhibition |
| 05/26/2011 | US20110124741 Radiosensitizer compositions comprising schisandra chinensis(turcz.)baill and methods for use |
| 05/26/2011 | US20110124740 Novel diaryl hepatonoid-based compounds and use thereof |
| 05/26/2011 | US20110124739 Use of Sphingosine-1-phosphate (S1P) Receptor Agonists for the Treatment of Brain Degenerative Diseases |
| 05/26/2011 | US20110124737 Enhanced bimatoprost ophthalmic solution |
| 05/26/2011 | US20110124736 Compositions and methods for stimulating hair growth |
| 05/26/2011 | US20110124735 Carbonylamino derivatives useful for the treatment of certain inflammatory disorders |
| 05/26/2011 | US20110124733 Therapeutic or prophylactic agent for diabetes, obesity, dyslipidemia or metabolic syndrome comprising benzylamine derivative or pharmaceutically acceptable acid |
| 05/26/2011 | US20110124732 Deuterium-enriched disufenton |
| 05/26/2011 | US20110124731 Treatment Of Neurodegenerative Diseases And Cancer Of The Brain Using Histone Deacetylase Inhibitors |
| 05/26/2011 | US20110124730 Oral pharmaceutical suspension comprising paracetamol and ibuprofen |
| 05/26/2011 | US20110124728 Dha enrichment process |
| 05/26/2011 | US20110124727 Oxybuprocaine-Containing Analgesic/Antipruritic External Preparation |
| 05/26/2011 | US20110124726 Novel carboxylic acid derivatives |
| 05/26/2011 | US20110124725 Treatment for Meibomian Gland Dysfunction or Obstruction |
| 05/26/2011 | US20110124724 Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potasium level in the blood |
| 05/26/2011 | US20110124723 Compounds for Preventing and Treating Plasmodium Infections |
| 05/26/2011 | US20110124722 Compositions and methods for treating hypercholesterolemia using ortanique peel extract |
| 05/26/2011 | US20110124721 Methods of treating traumatic brain injury by administering baicalein preparation |
| 05/26/2011 | US20110124720 Compositions and methods for treating immune disorders |
| 05/26/2011 | US20110124719 Composition for promoting production of hyaluronic acid containing kaempferol and quercetin |
| 05/26/2011 | US20110124718 Reduction Of Acetaminophen Toxicity By Dietary Milk Thistle Extract |
| 05/26/2011 | US20110124717 Methods for Bone Treatment by Modulating an Arachidonic Acid Metabolic or Signaling Pathway |
| 05/26/2011 | US20110124715 Antiviral Oligonucleotides Having a Conserved G4 Core Sequence |
| 05/26/2011 | US20110124714 pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof |
| 05/26/2011 | US20110124713 Sam-ii riboswitch and uses thereof |
| 05/26/2011 | US20110124712 Anti-cancer composition comprising microrna molecules |
| 05/26/2011 | US20110124711 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE |
| 05/26/2011 | US20110124710 Composition and methods of rnai therapeutics for treatment of cancer and other neovascularization diseases |
| 05/26/2011 | US20110124709 Rna antagonists targeting gli2 |
| 05/26/2011 | US20110124708 Rnai-mediated inhibition of ocular hypertension targets |
| 05/26/2011 | US20110124707 Methods And Compositions For Reducing Viral Genome Amounts In A Target Cell |
| 05/26/2011 | US20110124706 SOCS3 Inhibition Promotes CNS Neuron Regeneration |
| 05/26/2011 | US20110124705 Prodrugs of alpha-2-delta ligands, pharmaceutical compositions and uses thereof |
| 05/26/2011 | US20110124704 Deuterium-enriched atorvastatin |
| 05/26/2011 | US20110124703 Molecules comprising a bis(heteroaryl)maleimide backbone, and use thereof in the inhibition of dde/ddd enzymes |
| 05/26/2011 | US20110124702 Nanosuspension of a Poorly Soluble Drug via Microfluidization Process |
| 05/26/2011 | US20110124701 Use of hdac inhibitors for the treatment of lymphomas |
| 05/26/2011 | US20110124700 Systems and methods of cancer staging and treatment |
| 05/26/2011 | US20110124699 Method for treating nervous system disorders and conditions |
| 05/26/2011 | US20110124697 Compositions based on aminoacids, suitable for the treatment of heart failure |
| 05/26/2011 | US20110124696 Sulfone Compounds Which Modulate The CB2 Receptor |
| 05/26/2011 | US20110124695 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors |
| 05/26/2011 | US20110124694 Bioavailable compositions of metaxalone and processes for producing the same |
| 05/26/2011 | US20110124693 5-phenyl-4-methyl-thiazol-2-yl-amine derivatives as inhibitors of phosphatidylinositol 3 kinase enzymes (pi3) for the treatment of inflammatory diseases |
| 05/26/2011 | US20110124692 Crystalline forms of thiazolidinedione compound and its manufacturing method |
| 05/26/2011 | US20110124691 Organic Compounds |
| 05/26/2011 | US20110124690 Compositions and methods for treating cancer or a neurotrophic disorder |
| 05/26/2011 | US20110124689 Process for preparing atazanavir bisulfate and novel forms |
| 05/26/2011 | US20110124688 Nicotine receptor agonists in stem cell and progenitor cell recruitment |
| 05/26/2011 | US20110124687 Pharmaceutical composition |
| 05/26/2011 | US20110124686 Sultam derivatives |
| 05/26/2011 | US20110124685 Anesthetic Compounds |
| 05/26/2011 | US20110124684 Aminopyrazole triazolothiadiazole inhibitors of c-met protien kinase |
| 05/26/2011 | US20110124683 Use of CRTH2 Antagonist Compounds |
| 05/26/2011 | US20110124682 Pharmaceutical composition comprising rebamipide |